Childhood Oligodendroglioma, also known as oligodendroglioma, childhood, is related to glioma susceptibility 1 and anaplastic oligodendroglioma, and has symptoms including headache and seizures. An important gene associated with Childhood Oligodendroglioma is KIAA1549 (KIAA1549), and among its related pathways/superpathways are Chromatin Regulation / Acetylation and Vemurafenib Pathway, Pharmacodynamics. The drugs Trametinib and Dabrafenib have been mentioned in the context of this disorder. Affiliated tissues include brain and spinal cord, and related phenotypes are Increased shRNA abundance (Z-score > 2) and behavior/neurological